SCHEMBL4838461

SCHEMBL4838461

CCN(C(=O)OC(C)(C)C)c1ccc(C=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
ALDH3A1 P30838 1/20 0.47
ALDH1A3 P47895 1/20 0.47
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
CYP2A6 P11509 1/20 0.42
CYP2A13 Q16696 1/20 0.42
TSHR P16473 2/20 0.40
HTT P42858 1/20 0.39
GLA P06280 1/20 0.39
MLYCD O95822 2/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
KMT2A Q03164 1/20 0.35
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208342 0.87 NPC1 (0.41) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1
SCHEMBL31378320 0.84 KDM4E (0.39) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1
SCHEMBL4477043 0.84 NR1H4 (0.41) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1
SCHEMBL29742747 0.84 KDM4E (0.39) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1
SCHEMBL3894800 0.84 TSHR (0.42) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL22042475 0.83 TRPM8 (0.45) ALDH1A1NPC1RAB9AHTTGLA
SCHEMBL21309865 0.83 HDAC8 (0.40) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1
SCHEMBL4738587 0.83 TSHR (0.43) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL2552511 0.83 TSHR (0.41) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL7546488 0.82 CYP2A6 (0.46) ALDH1A1ALDH3A1ALDH1A3KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197277-B1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION INC (US) 2021-12-22 EP disclosed
US-20190330218-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS INC (US) 2019-10-31 US disclosed
US-7320995-B2 Benzimidazoles and benzothiazoles as inhibitors of map kinase ELI LILLY AND COMPANY (US) 2008-01-22 US disclosed
EP-1554272-B1 BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE LILLY CO ELI (US) 2006-10-25 EP disclosed
US-20050272791-A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase EIL LILLY AND COMPANY (US) 2005-12-08 US disclosed
EP-1554272-A1 BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE ELI LILLY AND COMPANY (US) 2005-07-20 EP disclosed
WO-2004014900-A1 BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE ELI LILLY AND COMPANY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272791-A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase MAP3K8, MAPK8, MAPK1 ALDH1A1 1864/4885ALDH3A1 2527/4885ALDH1A3 3064/4885
US-20190330218-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) CDK7, CDK3, CDK9 ALDH1A1 3928/4885ALDH3A1 2990/4885ALDH1A3 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.